Clinilabs

Clinilabs is a specialized contract research organization (CRO) dedicated solely to central nervous system (CNS) clinical trials, distinguishing itself from generalist CROs. Founded in 2004 and headquartered in New York, USA, it offers a full suite of services including Phase 2-3 trial management, early phase development, clinical research units, and regulatory advisory, supported by proprietary technology and core labs. With over 25 years of collective experience, the company has completed more than 800 CNS trials and contributed to over 30 marketed products across 25+ CNS indications, establishing itself as a leader in neurotherapeutic development. Its business model is service-based, generating revenue from pharmaceutical, biotech, and MedTech clients.

Integrated clinical trial technology suite (EDC, CTMS), specialized Corelabs for CNS biomarkers, and real-time device integration capabilities for MedTech/NeuroTech trials.

Clinilabs competes with large, global CROs (e.g., IQVIA, ICON) that offer broad services and with smaller, specialized CROs focusing on neuroscience. Its key differentiator is its exclusive, deep focus on CNS across both drugs and devices, supported by a long track record and proprietary processes.